Cladis Investment Advisory, LLC Merck & Co., Inc. Transaction History
Cladis Investment Advisory, LLC
- $144 Billion
- Q3 2024
A detailed history of Cladis Investment Advisory, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 11,527 shares of MRK stock, worth $1.15 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
11,527
Previous 10,777
6.96%
Holding current value
$1.15 Million
Previous $1.33 Billion
1.89%
% of portfolio
0.91%
Previous 0.97%
Shares
19 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$25 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.9 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.59 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.92 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $253B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...